Frailty Assessment in Older Adults with Cancer
Part of Blood & lymphatic, Brain & nervous system clinical trials.
This study evaluates how to better assess and manage frailty (age-related weakness and vulnerability) in older cancer patients aged 70 and up who are starting chemotherapy or other cancer treatments. The goal is to help doctors tailor treatment plans to each patient's individual strength and health status.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 70 or older
- Diagnosed with lung cancer, gastrointestinal cancer, mesothelioma, multiple myeloma, or lymphoma
- Eligible to start first-line cancer treatment (initial chemotherapy or systemic therapy)
- Able to perform daily activities with minimal to moderate limitations (ECOG performance status 0–3)
- No brain tumors or symptomatic bone lesions (for solid tumor patients)
- No serious heart disease (NYHA class III or IV) and no pacemakers or implantable defibrillators
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how body composition (like muscle and fat) changes in older adults with cancer who are starting treatment. It aims to learn more about how these changes may affect health and treatment outcomes.
This study looks at how muscle loss (sarcopenia) might affect side effects from cancer treatments. If you are starting a new cancer treatment, a CT scan before treatment can help doctors predict your risk of side effects.
This study looks at how frailty affects the course of chronic diseases and how chronic diseases affect frailty. It may help understand aging-related conditions better.
This study looks at whether doctors can spot “low muscle” (sarcopenia) in everyday clinic care for people with ovarian or endometrial cancer who are planning to start chemotherapy. It may help your care team identify muscle loss early and potentially support better treatment planning.
This study compares different ways to check frailty (a measure of how well your body handles stress) in women with breast cancer who are 50 or older. The goal is to find which screening tool best predicts health outcomes during treatment.
This trial studies simple “frailty” assessments (tests of strength, memory, and daily functioning) to better predict risk in people with gynecologic cancers who are planning or having surgery. If you qualify, the results may help doctors identify who needs extra support before and after surgery.
Hear when a new Sarcopenia in Elderly trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.